Contact Us
Drug Search Results
More Filters [+]

Narlaprevir

Alternative Names: narlaprevir
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: HCV-NS3/4A Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Russia

Approved Indications: None

Known Adverse Events: None

Company: R-Pharm
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Narlaprevir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hepatitis C, Chronic|Hepatitis A

Phase 2: Hepatitis A|Hepatitis C, Chronic

Phase 1: Hepatitis C, Chronic|Liver Cirrhosis|Coinfection|Cross Infection

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CJ05013053

P2

Completed

Hepatitis C, Chronic|Hepatitis A

2020-04-08

24%
CJ05013046

P2

Completed

Hepatitis A|Hepatitis C, Chronic

2018-08-29

22%
CJ05013019

P1

Completed

Coinfection|Cross Infection|Hepatitis C, Chronic

2017-06-24

PIONEER

P3

Completed

Hepatitis A|Hepatitis C, Chronic

2016-03-23

46%

Recent News Events

Date

Type

Title

09/01/2023

PubMed

 The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: an insight into molecular docking, ADMET analysis, and molecular dynamics simulation.

04/28/2023

PubMed

 Recent Advances in Covalent Drug Discovery.

10/12/2022

PubMed

 [Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C].

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions